All ProductsDisplaying Products by Catalog Number (6000 - 6099)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800
| Cat. No. | Product Name / Activity |
|---|---|
| 6000 | TP 472 |
| Potent BRD9/7 inhibitor | |
| 6002 | Trolox |
| Antifade reagent; antioxidant vitamin E derivative; cell permeable and water soluble | |
| 6004 | PF 06281355 |
| Selective myeloperoxidase (MPO) inhibitor | |
| 6005 | PF 3758309 dihydrochloride |
| Potent PAK4 inhibitor; orally available | |
| 6007 | INCB 024360-analog |
| Potent indoleamine 2,3-dioxygenase (IDO) inhibitor | |
| 6008 | TP 064 |
| Potent and selective PRMT 4 inhibitor | |
| 6009 | B I09 |
| IRE1 endonuclease inhibitor; cell permeable | |
| 6013 | TAPI 2 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6016 | IN 1130 |
| Potent and selective inhibitor of TGF-βRI | |
| 6018 | Nicotinamide Riboside |
| NAD+ precursor; substrate for nicotinamide riboside kinases | |
| 6019 | Diprotin A |
| Dipeptidyl peptidase IV (DPP-IV) inhibitor | |
| 6024 | PF 04671536 hydrochloride |
| Potent and selective PDE8B/8A inhibitor | |
| 6025 | (S)-Crizotinib |
| MTH1 inhibitor | |
| 6029 | FRAX 597 |
| Potent group I PAK inhibitor | |
| 6031 | Calcitonin (human) |
| Endogenous calcitonin agonist; inhibits bone resorption | |
| 6033 | (R)-MG 132 |
| Potent 20S proteasome inhibitor | |
| 6037 | LM22B 10 |
| TrkB and TrkC agonist; brain penetrant | |
| 6038 | SR 10067 |
| Selective Rev-Erbα/β agonist; anxiolytic | |
| 6043 | AMBMP hydrochloride |
| Wnt canonical signaling activator; also tubulin polymerization inhibitor | |
| 6045 | NITD 008 |
| Antiflaviviral; active against Zika, Dengue and Hepatitis C viruses | |
| 6047 | BOP |
| Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs | |
| 6051 | G 5555 |
| High affinity group I PAK inhibitor | |
| 6052 | BAY 58-2667 hydrochloride |
| Potent soluble guanylyl cyclase (sGC) activator | |
| 6053 | LDN 193189 dihydrochloride |
| Potent and selective ALK2 and ALK3 inhibitor; inhibits BMP4 signaling; promotes neural induction of hPSCs | |
| 6055 | SPT Imidazopyridine 1 |
| Potent serine palmitoyl transferase inhibitor | |
| 6058 | ATN 161 |
| α5β1 integrin receptor antagonist | |
| 6060 | AZD 2461 |
| Potent PARP inhibitor; orally bioavailable | |
| 6065 | 2-NBDG |
| Fluorescent glucose uptake indicator | |
| 6068 | Lin28 1632 |
| RNA binding protein Lin28 inhibitor; promotes mESC differentiation; also bromodomain inhibitor | |
| 6070 | Pladienolide B |
| mRNA splicing inhibitor; antitumor | |
| 6071 | CZC 25146 |
| Potent LRRK2 inhibitor | |
| 6075 | Nutlin 3a |
| MDM2 antagonist; active enantiomer of Nutlin-3 (Cat. No. 3984) | |
| 6076 | Ani 9 |
| Potent and selective TMEM16A (Anoctamin-1; ANO1) blocker | |
| 6078 | BPTU |
| P2Y1 allosteric antagonist | |
| 6082 | AMG 837 hemicalcium salt |
| Potent FFA1 (GPR40) partial agonist | |
| 6083 | PSB 12379 |
| Ecto-5'-nucleotidase (CD73) inhibitor | |
| 6085 | AZD 1283 |
| High affinity P2Y12 antagonist | |
| 6086 | AMP PNP |
| Kir6 blocker; non-hydrolyzable AMP analog | |
| 6087 | Perifosine |
| PKB/Akt inhibitor; also modulates Kv2.1 current | |
| 6088 | SB 3CT |
| High affinity and selective MMP2 inhibitor | |
| 6089 | Nexinhib20 |
| Rab27 inhibitor; inhibits neutrophil exocytosis; active in vivo | |
| 6090 | Spexin |
| Potent GAL2/3 agonist; exhibits anxiolytic effects in vivo | |
| 6092 | TDZD 8 |
| Selective non-ATP competitive inhibitor of GSK 3β | |
| 6094 | 2R,6R-Hydroxynorketamine hydrochloride |
| Enhances AMPA currents; decreases D-serine (a NMDA co-agonist); lacks ketamine-related side effects | |
| 6095 | 2S,6S-Hydroxynorketamine hydrochloride |
| Decreases D-serine (a NMDA co-agonist); antidepressant | |
| 6098 | Lalistat 1 |
| Potent and selective LAL inhibitor | |
| 6099 | Lalistat 2 |
| Selective LAL inhibitor |